Zusammenfassung
Erläutert werden alle relevanten Funktionsteste mit ausführlicher Darstellung von Indikationen, Kontraindikationen, Nebenwirkungen, Testvorbereitung, Rahmenbedingungen, konkreten Handlungsanleitung der eigentlichen Testdurchführung sowie der Interpretation der Testergebnisse. Es werden immer konkrete Normbereiche und Cut-off-Werte angegeben, auch für besondere Situationen (Geschlecht, Alter, BMI, Pubertätsphasen, Zyklusphasen, akute Erkrankungen, Medikamente etc.). Ein besonderes Merkmal ist die Betonung der Testvorbereitung, -durchführung und -interpretation sowie des interdisziplinären Charakters. Dieses Kapitel gibt einen praktischen Überblick über die radiologischen und nuklearmedizinischen Bildgebungsverfahren für wichtige Endokrinopathien. Klassische Kardinalbefunde der Bildgebung werden anhand von Abbildungen erklärt und Sensitivitäten und Spezifitäten für die einzelnen Verfahren angegeben. Die Bedeutung der Hounsfield-Einheiten im CT und der Fettsuppression im MRT für die adrenale Bildgebung wird detailliert besprochen.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Literatur
Singer AA, Obuchowski NA, Einstein DM, Paushter DM (1994) Metastasis or adenoma? Computed tomographic evaluation of the adrenal mass. Cleve Clin J Med 61:200–205
Szolar DH, Kammerhuber F (1997) Quantitative CT evaluation of adrenal gland masses: a step forward in the differentiation between adenomas and nonadenomas? Radiology 202:517–521
Korobkin M, Lombardi TJ, Aisen AM, Francis IR, Quint LE, Dunnick NR, Londy F, Shapiro B, Gross MD, Thompson NW (1995) Characterization of adrenal masses with chemical shift and gadolinium-enhanced MR imaging. Radiology 197:411–418
Outwater EK, Siegelman ES, Radecki PD, Piccoli CW, Mitchell DG (1995) Distinction between benign and malignant adrenal masses: value of T1-weighted chemical-shift MR imaging. Am J Roentgenol 165:579–583
Rand T, Lippitz P, Kink E, Huber H, Schneider B, Imhof H, Trattnig S (2002) Evaluation of pituitary microadenomas with dynamic MR imaging. Eur J Radiol 41:131–135
Schwerk WB, Gorg C, Gorg K, Restrepo IK (1994) Adrenal pheochromocytomas: a broad spectrum of sonographic presentation. J Ultrasound Med 13:517–521
Suzuki Y, Sasagawa H, Suzuki H, Izumi T, Kaneko H, Nakada T (2001) The role of ultrasonography in the detection of adrenal masses: comparison with computed tomography and magnetic resonance imaging. Int Urol Nephrol 32:303–306
Liao JT, Huang TH, Wu BY (2001) Ultrasonographic evaluation of adrenal masses. Hunan yi ke da xue xue bao = Hunan yike daxue xuebao = Bull Hunan Med Univ 26:453–454
Niu L, Hao Y, Zhou C, Dai J (2002) Diagnostic significance of ultrasonography and CT for large upper abdominal mass. Chin Med J (Engl) 115:1358–1362
Williams DT, Dann S, Wheeler MH (2003) Phaeochromocytoma – views on current management. Eur J Surg Oncol 29:483–490
Trojan J, Schwarz W, Sarrazin C, Thalhammer A, Vogl TJ, Dietrich CF (2002) Role of ultrasonography in the detection of small adrenal masses. Ultraschall Med 23:96–100
Gutekunst R, Becker W, Hehrmann R, Olbricht T, Pfannenstiel P (1988) Ultrasonic diagnosis of the thyroid gland. Dtsch Med Wochenschr 113:1109–1112
Delange F, Benker G, Caron P, Eber O, Ott W, Peter F, Podoba J, Simescu M, Szybinsky Z, Vertongen F, Vitti P, Wiersinga W, Zamrazil V (1997) Thyroid volume and urinary iodine in European schoolchildren: standardization of values for assessment of iodine deficiency. Eur J Endocrinol 136:180–187
Göke B, Fürst H, Reincke M, Auernhammer CJ (Hrsg) (2008) Manual Endokrine Tumoren – Tumorzentrum München. W. Zuckschwerdt-Verlag, München, S 13
Nagele W, Nagele J (2009) Aktueller Stand der B-Bild-Schilddrüsensonographie. J Klein Endokrinol Stoffwechs 2:7–14
Führer D, Bockisch A, Schmid KW (2012) Euthyreote Struma mit und ohne Knoten – Diangostik und Therapie. Dtsch Ärzteblatt 109:506–516
Frates MC, Benson CB, Charboneau JW et al (2005) Management of thyroid nodules detected at US: society of radiologists in ultrasound consensus conference statement. Radiology 237:704–800
Allelein S, Feldkamp J, Schott M (2017) Diagnostik und Therapie der Struma multinodosa im Jahr 2017. DMW 142:1097–1100
Haugen BR, Alexander EK, Bible KC et al (2016) American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American Thyroid Association guidelines task force on thyroid nodules and differentiated thyroid cancer. Thyroid 26:1–33
Bojunga J, Dauth N, Berner C, Meyer G, Holzer K, Voelkl L, Herrmann E, Schroeter H, Zeuzem S, Friedrich-Rust M (2012) Acoustic radiation force impulse imaging for differentiation of thyroid nodules. PLoS One 7(8):e42735
Rubaltelli L, Corradin S, Dorigo A, Stabilito M, Tregnaghi A, Borsato S, Stramare R (2009) Differential diagnosis of benign and malignant thyroid nodules at elastosonography. Ultraschall Med 30:175–179
Rickes S, Sitzy J, Neye H, Ocran KW, Wermke W (2003) High-resolution ultrasound in combination with colour-Doppler sonography for preoperative localization of parathyroid adenomas in patients with primary hyperparathyroidism. Ultraschall Med 24:85–89
Haber RS, Kim CK, Inabnet WB (2002) Ultrasonography for preoperative localization of enlarged parathyroid glands in primary hyperparathyroidism: comparison with (99m)technetium sestamibi scintigraphy. Clin Endocrinol (Oxf) 57:241–249
Solorzano CC, Carneiro-Pla DM, Irvin GL (2006) Surgeon-performed ultrasonography as the initial and only localizing study in sporadic primary hyperparathyroidism. J Am Coll Surg 202:18–24
Siperstein A, Berber E, Mackey R, Alghoul M, Wagner K, Milas M (2004) Prospective evaluation of sestamibi scan, ultrasonography, and rapid PTH to predict the success of limited exploration for sporadic primary hyperparathyroidism. Surgery 136:872–880
Gotway MB, Reddy GP, Webb WR, Morita ET, Clark OH, Higgins CB (2001) Comparison between MR imaging and 99mTc MIBI scintigraphy in the evaluation of recurrent of persistent hyperparathyroidism. Radiology 218:783–790
Melton GB, Somervell H, Friedman KP, Zeiger MA, Cahid Civelek A (2005) Interpretation of 99mTc sestamibi parathyroid SPECT scan is improved when read by the surgeon and nuclear medicine physician together. Nucl Med Comm 26:633–638
Lumachi F, Zucchetta P, Marzola MC, Boccagni P, Angelini F, Bui F, D’Amico DF, Favia G (2000) Advantages of combined technetium-99m-sestamibi scintigraphy and high-resolution ultrasonography in parathyroid localization: comparative study in 91 patients with primary hyperparathyroidism. Eur J Endocrinol 143:755–760
Ruda JM, Hollenbeak CS, Stack BC Jr (2005) A systematic review of the diagnosis and treatment of primary hyperparathyroidism from 1995 to 2003. Otolaryngol Head Neck Surg 132:359–372
Jones JM, Russell CF, Ferguson WR, Laird JD (2001) Pre-operative sestamibi-technetium subtraction scintigraphy in primary hyperparathyroidism: experience with 156 consecutive patients. Clin Radiol 56:556–559
Gabriel M, Decristoforo C, Kendler D, Dobrozemsky G, Heute D, Uprimny C, Kovacs P, Von Guggenberg E, Bale R, Virgolini IJ (2007) 68Ga-DOTA-Tyr3-octreotide PET in neuroendocrine tumors: comparison with somatostatin receptor scintigraphy and CT. J Nucl Med 48:508–518
Murray IPC, Ell PJ (Hrsg) (1999) Nuclear medicine in clinical diagnosis and treatment. Churchill Livingston, London
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer-Verlag GmbH Deutschland
About this chapter
Cite this chapter
Schäffler, A. et al. (2018). Radiologisches und nuklearmedizinisches Basiswissen für die Diagnostik in der Endokrinologie. In: Schäffler, A. (eds) Funktionsdiagnostik in Endokrinologie, Diabetologie und Stoffwechsel. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-55914-7_20
Download citation
DOI: https://doi.org/10.1007/978-3-662-55914-7_20
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-662-55913-0
Online ISBN: 978-3-662-55914-7
eBook Packages: Medicine (German Language)